News
1mon
Distractify on MSN‘Sold on SLC’ Star Matt Jones’s Marriage Is Going Strong Despite His Strip Club ConfessionFor one cast member, Matt Jones, the latter caused him to spill a secret that could've cost him a significant relationship. While Matt has been known to ruffle a few feathers amongst his co-stars ...
GSK reached a settlement with plaintiff Isaac Dixon, resolving a case related to its discontinued heartburn medicine Zantac allegedly causing prostate cancer, filed in Illinois State court.
Hosted on MSN1mon
KSR Show, 4/21: Matt Jones returns to KSR from AmsterdamAfter more than two weeks away, Matt Jones returns to KSR from across the pond today. KSR’s morning show returns to its regular format, featuring the entire crew, live from 10 a.m. to noon ...
Hosted on MSN1mon
Matt Jones pushes back on Kentucky’s alleged $20M NIL budget: “It is nowhere near that number”Even Dick Vitale caught wind of it. But KSR’s Matt Jones shut down that talk during Wednesday’s edition of the KSR Radio Show. While Kentucky is expected to be among the top three schools in ...
Ole Miss running back Matt Jones went down to the field with what appeared to be a fake injury in Saturday’s game against Kentucky, earning criticism during the broadcast by ABC’s announcers.
Matt Jones announced on Tuesday’s show that he signed a five-year extension to keep hosting KSR through the end of 2029, ...
Story by Matt Kenyon • 1w F TSE 100 p harma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a City broker.
GSK said it reached a confidential settlement with plaintiff Ronald Kimbrow, resolving a case related to its discontinued heartburn medicine Zantac in the Illinois state court, without disclosing ...
GSK received approval from U.K.'s medicines regulatory body to bring its blood-cancer blockbuster candidate Blenrep back to the market, enabling the British pharma giant to expand its oncology ...
For the first time, News 8 is now hearing from Carroll County Coroner Matt Jones about why he went to such extensive lengths to conduct what resembled a mini-trial in the case. Jones has served as ...
GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results